13F Data
13F filer · CIK 1274413

SECTORAL ASSET MANAGEMENT INC

MONTREAL, A8 · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$143.3M
+$22.6M vs prior
Positions
82
New / sold out
15 / 10
Added / reduced
17 / 17
Turnover
19.3%
buys $40.6M · sells $25.5M
Top-10 weight
39.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewORUKA THERAPEUTICS INC+41,987–+$4.0M
NewDEFINIUM THERAPEUTICS INC+78,310–+$3.7M
NewIRHYTHM HOLDINGS INC+26,070–+$3.1M
NewAVALO THERAPEUTICS INC+119,923–+$2.2M
AddedSUMMIT THERAPEUTICS+150,565+216.3%+$2.2M
NewCRESCENT BIOPHARMA INC.+121,300–+$2.2M
AddedARCUS BIOSCIENCES+65,800+146.0%+$2.0M
NewPULSE BIOSCIENCES INC+67,895–+$1.9M
AddedDEXCOM INC+27,525+118.5%+$1.9M
AddedBIONTECH SE+19,705+88.9%+$1.8M
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outEVOMMUNE INC-589,005-100.0%$-13.5M
ReducedGILEAD SCIENCES INC-6,870-25.0%$-868.0K
Sold outRAPPORT THERAPEUTICS-25,421-100.0%$-835.0K
ReducedVERTEX PHARMA-1,575-22.5%$-782.3K
Sold outBOUNDLESS BIO-678,574-100.0%$-746.4K
Sold outASCENDIS PHARMA A S-2,800-100.0%$-728.3K
ReducedUNITEDHEALTH GRP INC-1,722-11.5%$-715.7K
ReducedABBOTT LABS-7,498-29.3%$-680.4K
ReducedARGENX SE-733-20.6%$-680.1K
ReducedSTRUCTURE THERAPEUTICS-9,777-69.3%$-524.7K
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $3.4BQ3 2013: $2.1BQ4 2013: $2.3BQ1 2014: $2.4BQ2 2014: $2.4BQ3 2014: $2.4BQ4 2014: $2.2BQ1 2015: $2.6BQ2 2015: $2.4BQ3 2015: $2.2BQ4 2015: $2.3BQ1 2016: $2.1BQ2 2016: $968.4MQ3 2016: $1.0BQ4 2016: $902.7MQ1 2017: $856.3MQ2 2017: $914.4MQ3 2017: $776.3MQ4 2017: $800.3MQ1 2018: $912.1MQ2 2018: $894.4MQ3 2018: $941.9MQ4 2018: $735.6MQ1 2019: $831.4MQ2 2019: $836.3MQ3 2019: $579.6MQ4 2019: $670.2MQ1 2020: $520.9MQ2 2020: $1.1BQ3 2020: $1.2BQ4 2020: $1.4BQ1 2021: $1.3BQ2 2021: $1.2BQ3 2021: $1.2BQ4 2021: $664.4MQ1 2022: $563.3MQ2 2022: $496.3MQ3 2022: $507.6MQ4 2022: $516.8MQ1 2023: $520.3MQ2 2023: $599.8MQ3 2023: $513.5MQ4 2023: $232.2MQ1 2024: $254.4MQ2 2024: $246.1MQ3 2024: $169.3MQ4 2024: $149.8MQ1 2025: $128.5MQ2 2025: $151.5MQ3 2025: $162.0MQ4 2025: $124.8MQ1 2026: $120.7MQ2 2026: $143.3M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1CONTINEUM THERAPEUTICSCL A727,587$11.9M8.32%
2SHOULDER INNOVATIONSCOMMON STOCK430,407$8.7M6.09%
3LLYELI LILLY & CO6,354$7.6M5.32%
4UNITEDHEALTH GRP INCCOM13,235$5.5M3.84%
5JNJJOHNSON & JOHNSON18,218$4.6M3.23%
6ORUKA THERAPEUTICS INCCOM41,987$4.0M2.79%
7BIONTECH SESP ADR41,869$3.9M2.72%
8DEFINIUM THERAPEUTICS INCCOM SHS78,310$3.7M2.57%
9DEXCOM INCCOM50,756$3.4M2.39%
10ARCUS BIOSCIENCESCOM110,870$3.4M2.39%
72 more rows. Subscribe for $29/month to see every row, download the data and use the API.